Haida Hirofumi, Mori Atsuo, Funaishi Koji
Cardiovascular Surgery, Kawasaki Municipal Hospital, Kawasaki, JPN.
Cureus. 2025 May 9;17(5):e83807. doi: 10.7759/cureus.83807. eCollection 2025 May.
Hemolysis following surgical aortic valve replacement (SAVR) is typically attributed to paravalvular leakage or prosthetic valve dysfunction. However, we present a rare case of hemolytic anemia caused by dynamic left ventricular outflow tract obstruction (LVOTO) due to septal hypertrophy following SAVR with a bioprosthetic valve. A 78-year-old woman underwent SAVR with annular enlargement via the Manougian procedure. Despite an uneventful intraoperative course and initial recovery, she developed progressive hemolysis postoperatively without evidence of valve dysfunction or paravalvular regurgitation. Echocardiography revealed dynamic LVOTO and moderate mitral regurgitation (MR). Conservative treatment, including beta blockers and calcium channel blockers, led to improvement of the obstruction and resolution of hemolysis. This case highlights the need to consider dynamic LVOTO in the differential diagnosis of post-SAVR hemolysis and to more aggressively evaluate the indication for concomitant septal myectomy in patients with preexisting hypertrophy.
外科主动脉瓣置换术(SAVR)后的溶血通常归因于瓣周漏或人工瓣膜功能障碍。然而,我们报告了一例罕见病例,一名接受生物瓣膜SAVR术后因间隔肥厚导致动态左心室流出道梗阻(LVOTO)引起溶血性贫血。一名78岁女性通过马努吉安手术进行了带瓣环扩大的SAVR。尽管术中过程顺利且初期恢复良好,但她术后出现进行性溶血,无瓣膜功能障碍或瓣周反流的证据。超声心动图显示动态LVOTO和中度二尖瓣反流(MR)。包括β受体阻滞剂和钙通道阻滞剂在内的保守治疗使梗阻得到改善,溶血得以缓解。该病例强调在SAVR后溶血的鉴别诊断中需要考虑动态LVOTO,并更积极地评估合并有肥厚的患者同期行间隔肌切除术的指征。